BACK TO CONTENTS   |    PDF   |    NEXT

Title

Computer aided Screening of Accacia nilotica phytochemicals against HCV NS3/4a

 

Authors

Mahim Khan1, Muhammad Qasim1, Usman Ali Ashfaq1*, Sobia Idrees1 & Masoud Shah2

 

Affiliation

1Department of Bioinformatics and Biotechnology, Government College University (GCU), Faisalabad, Pakistan; 2Department of Biochemistry Abdul Wali Khan University Mardan, Mardan 23200, Pakistan

 

Email

usmancemb@gmail.com; *Corresponding author

 

Article Type

Hypothesis

 

Date

Received June 20, 2013; Accepted June 25, 2013; Published August 07, 2013

 

Abstract

Background: HCV has become a leading cause of liver cirrhosis and hepatocellular carcinoma and is a major health concern worldwide. To date, there is no vaccine available in the market to tackle this disease, therefore there is a strong need to develop antiviral compounds that can target all genotypes of HCV with the same efficiency. Medicinal plants have low cost and are less toxic therefore, extracts of medicinal plants can serve as important antiviral agents against HCV. This study was designed to screen phytochemicals of Accacia nilotica to find a potent drug candidate that can inhibit HCV infection effectively. Results: Docking of NS3/4A protease and Flavonoids of Accacia nilotica revealed that most of the flavonoids bound deeply with the active site of NS3/4A protease. Compound 01 showed a high ranking on docking score. All other compounds also showed reliable docking scores and had interactions with the binding cavity of NS3/4A protease, suggesting them as a potent drug candidate to block HCV replication. Conclusion: To recognize binding interactions of Accacia nilotica phytochemicals with NS3/4A protease, molecular docking was performed to find potential inhibitor against NS3/4A protease of HCV. After post docking analysis, important interactions were found between active compounds and active site of NS3/4A protease. It can be concluded from the study that phytochemicals of Accacia nilotica may serve as a potential drug candidate with relatively simple structural changes against HCV NS3/4A protease.  

 

Citation

Khan et al. Bioinformation 9(14): 710-714 (2013)

 

ISSN

0973-2063

 

Publisher

Biomedical Informatics

 

License

This is an Open Access article which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. This is distributed under the terms of the Creative Commons Attribution License.